References
McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005;184(4):1293–1304
Reddick WE, Wang S, Xiong X, Glass JO, Wu S, Kaste SC et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer 2001;91(12):2230–2237
Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med 2003;44(6):930–942
Hawkins DS, Schuetze SM, Butrynski JE et al. [18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 2005;23(34):8828–8834
Hawkins DS, Rajendran JG, Conrad EU, III, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002;94(12):3277–3284
Aoki J, Watanabe H, Shinozaki T et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001;219(3):774–777
Goodin G, Shulkin B, Kaufman R, McCarville MB. PET/CT characterizaton of fibro-osseous defects in children. Am J Roentgenol 2006 (in press)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McCarville, B. The role of positron emission tomography in pediatric musculoskeletal oncology. Skeletal Radiol 35, 553–554 (2006). https://doi.org/10.1007/s00256-006-0149-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00256-006-0149-6